Unannounced phone-based pill counts for monitoring antiretroviral medication adherence in South Africa

References

• Phillips AN, Bansi-Matharu L, Cambiano V, et al. The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in Sub-Saharan africa: a modelling analysis. Lancet Glob Health. 2021;9(5):e620–e7.
   PubMed Web of Science ®Google Scholar
• Chandiwana NC, Serenata CM, Owen A, et al. Impact of long-acting therapies on the global HIV epidemic. AIDS. 2021;35(Suppl 2):S137–S143.
   PubMedGoogle Scholar
• Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372–379.
   PubMed Web of Science ®Google Scholar
• Mouradjian MT, Heil EL, Sueng H, et al. Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen. SAGE Open Med. 2020;8:2050312120960570.
   Web of Science ®Google Scholar
• Fuge TG, Tsourtos G, Miller ER. A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people. PLoS One. 2020;15(5):e0233355.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Qiao S, Yang X, et al. Antiretroviral concentration in hair as a measure for antiretroviral medication adherence: a systematic review of global literature. AIDS Behav. 2020;24(1):311–330.
   PubMed Web of Science ®Google Scholar
• Quintana Y, Gonzalez Martorell EA, Fahy D, et al. A systematic review on promoting adherence to antiretroviral therapy in HIV-infected patients using mobile phone technology. Appl Clin Inform. 2018;9(2):450–466.
   PubMed Web of Science ®Google Scholar
• McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011;52(4):493–506.
   PubMed Web of Science ®Google Scholar
• Spinelli MA, Haberer JE, Chai PR, et al. Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions. Curr HIV/AIDS Rep. 2020;17(4):301–314.
   PubMed Web of Science ®Google Scholar
• Bangsberg DR, Hecht FM, Charlebois ED, et al. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS Behavior. 2001;5(3):275–281.
   Google Scholar
• Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36(5):1100–1102.
   PubMed Web of Science ®Google Scholar
• Haberer JE, Kiwanuka J, Nansera D, et al. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected ugandan children. PLoS One. 2012;7(5):e36737.
   PubMed Web of Science ®Google Scholar
• Haberer JE, Robbins GK, Ybarra M, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16(2):375–382.
   PubMed Web of Science ®Google Scholar
• Haberer JE, Baeten JM, Campbell J, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in east africa. PLoS Med. 2013;10(9):e1001511.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Amaral CM, Cherry C, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Amaral C, Swetsze C, et al. Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects. HIV Clin Trials. 2010;11(6):325–331.
   PubMed Web of Science ®Google Scholar
• Cai Y, Gong W, He W, et al. Residual effect of texting to promote medication adherence for villagers with schizophrenia in China: 18-Month follow-up survey after the randomized controlled trial discontinuation. JMIR Mhealth Uhealth. 2022;10(4):e33628.
   PubMed Web of Science ®Google Scholar
• Trief PM, Kalichman SC, Wang D, et al. Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study. Diabetes Res Clin Pract. 2022;184:109216.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Katner H, Eaton LA, et al. Randomized community trial comparing telephone versus Clinic-Based behavioral health counseling for people living with HIV in a rural setting. J Rural Health. 2022;38(4):728–739.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Amaral CM, Stearns HL, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22(7):1003–1006.
   PubMed Web of Science ®Google Scholar
• Campbell JI, Haberer JE. Cell Phone-Based and adherence device technologies for HIV care and treatment in Resource-Limited settings: Recent advances. Curr HIV/AIDS Rep. 2015;12(4):523–531.
   PubMed Web of Science ®Google Scholar
• DiPrete BL, Pence BW, Golin CE, et al. Antiretroviral adherence following prison release in a randomized trial of the imPACT intervention to maintain suppression of HIV viremia. AIDS Behav. 2019;23(9):2386–2395.
   PubMed Web of Science ®Google Scholar
• Raymond JF, Bucek A, Dolezal C, et al. Use of unannounced telephone pill counts to measure medication adherence among adolescents and young adults living with perinatal HIV infection. J Pediatr Psychol. 2017;42(9):1006–1015.
   PubMed Web of Science ®Google Scholar
• Bucek A, Raymond J, Leu CS, et al. Preliminary validation of an unannounced telephone pill count protocol to measure medication adherence among young adults with perinatal HIV infection. J Assoc Nurses AIDS Care. 2020;31(1):35–41.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Grebler T, Amaral CM, et al. Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs. J Gen Intern Med. 2013;28(3):399–405.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Katner H, Banas E, et al. HIV-related stigma and non-adherence to antiretroviral medications among people living with HIV in a rural setting. Soc Sci Med. 2020;258:113092.
   PubMed Web of Science ®Google Scholar
• Rosen RK, McGarrity LA, Salmoirago-Blotcher E, et al. Telephone-Delivered mindfulness training for people living with HIV: a qualitative 360 degrees inquiry. AIDS Behav. 2017;21(11):3194–3201.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Cherry C, Kalichman MO, et al. Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. Am J Public Health. 2011;101(3):531–538.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Kalichman MO, Cherry C, et al. Randomized factorial trial of Phone-Delivered support counseling and daily text message reminders for HIV treatment adherence. J Acquir Immune Defic Syndr. 2016;73(1):47–54.
   PubMed Web of Science ®Google Scholar
• Fredericksen R, Feldman BJ, Brown T, et al. Unannounced telephone-based pill counts: a valid and feasible method for monitoring adherence. AIDS Behav. 2014;18(12):2265–2273.
   PubMed Web of Science ®Google Scholar
• Hirsch-Moverman Y, Burkot C, Saito S, et al. Reaching the end of the line: Operational issues with implementing phone-based unannounced pill counts in resource-limited settings. PLoS One. 2017;12(10):e0185549.
   PubMed Web of Science ®Google Scholar
• Haberer JE, Kiwanuka J, Nansera D, et al. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010;14(6):1294–1301.
   PubMed Web of Science ®Google Scholar
• Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20(2):223–231.
   PubMed Web of Science ®Google Scholar
• Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17(13):1925–1932.
   PubMed Web of Science ®Google Scholar
• Nadkar MY, Bajpai S. Antiretroviral therapy: toxicity and adherence. J Assoc Physicians India. 2009;57:375–376.
   PubMedGoogle Scholar
• Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993;88(6):791–804.
   PubMed Web of Science ®Google Scholar
• Hahn JA, Fatch R, Wanyenze RK, et al. Decreases in self-reported alcohol consumption following HIV counseling and testing at mulago hospital, Kampala, Uganda. BMC Infect Dis. 2014;14(1):403.
   PubMedGoogle Scholar
• Marshall BDL, Tate JP, McGinnis KA, et al. Long-term alcohol use patterns and HIV disease severity. AIDS. 2017;31(9):1313–1321.
   PubMed Web of Science ®Google Scholar
• Williams EC, McGinnis KA, Rubinsky AD, et al. Alcohol use and antiretroviral adherence among patients living with HIV: is change in alcohol use associated with change in adherence? AIDS Behav. 2021;25(1):203–214.
   PubMed Web of Science ®Google Scholar
• Russell ML, Moralejo DG, Burgess ED. Paying research subjects: participants’ perspectives. J Med Ethics. 2000;26(2):126–130.
   PubMed Web of Science ®Google Scholar
• Wilson IB, Tchetgen E, Spiegelman D. Patterns of adherence with antiretroviral medications: an examination of between-medication differences. J Acquir Immune Defic Syndr. 2001;28(3):259–263.
   PubMed Web of Science ®Google Scholar
• Wilson IB, Tie Y, Padilla M, et al. Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States. AIDS. 2020;34(15):2239–2247.
   PubMed Web of Science ®Google Scholar
• Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–245.
   PubMed Web of Science ®Google Scholar